Unknown

Dataset Information

0

Epidemiology of Pediatric Multidrug-Resistant Tuberculosis in the United States, 1993-2014.


ABSTRACT: Background:Multidrug-resistant tuberculosis (MDR-TB) is an important global public health threat, but accurate estimates of MDR-TB burden among children are lacking. Methods:We analyzed demographic, clinical, and laboratory data for newly diagnosed pediatric (age <15 years) TB cases reported to the US National TB Surveillance System during 1993-2014. MDR-TB was defined as culture-confirmed TB disease with resistance to at least isoniazid and rifampicin. To ascertain potential underestimation of pediatric MDR-TB, we surveyed high-burden states for clinically diagnosed cases treated for MDR-TB. Results:Of 20789 pediatric TB cases, 5162 (24.8%) had bacteriologically confirmed TB. Among 4826 (93.5%) with drug susceptibility testing, 82 (1.7%) had MDR-TB. Most pediatric MDR-TB cases were female (n = 51 [62%]), median age was 5 years (interquartile range, 1-12 years), one-third were Hispanic (n = 28 [34%]), and two-thirds (n = 55 [67%]) were born in the United States. Most cases had additional resistance to ?1 other first-line drug (n = 66 [81%]) and one-third had resistance to ?1 second-line drug (24/73 tested). Of 77 who started treatment prior to 2013, 66 (86%) completed treatment and 4 (5%) died. Among the 4 high-TB-burden states/jurisdictions surveyed, there was 42%-55% underestimation of pediatric MDR-TB cases when using only culture-confirmed case definitions. Conclusions:Only one-quarter of pediatric TB cases had culture-confirmed TB, likely resulting in underestimation of true pediatric MDR-TB burden in the United States using strictly bacteriologic criteria. Better estimates of pediatric MDR-TB burden in the United States are needed and should include clinical diagnoses based on epidemiologic criteria.

SUBMITTER: Smith SE 

PROVIDER: S-EPMC5801661 | biostudies-literature | 2017 Oct

REPOSITORIES: biostudies-literature

altmetric image

Publications

Epidemiology of Pediatric Multidrug-Resistant Tuberculosis in the United States, 1993-2014.

Smith Sarah E SE   Pratt Robert R   Trieu Lisa L   Barry Pennan M PM   Thai Dzung T DT   Ahuja Shama Desai SD   Shah Sarita S  

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20171001 9


<h4>Background</h4>Multidrug-resistant tuberculosis (MDR-TB) is an important global public health threat, but accurate estimates of MDR-TB burden among children are lacking.<h4>Methods</h4>We analyzed demographic, clinical, and laboratory data for newly diagnosed pediatric (age <15 years) TB cases reported to the US National TB Surveillance System during 1993-2014. MDR-TB was defined as culture-confirmed TB disease with resistance to at least isoniazid and rifampicin. To ascertain potential unde  ...[more]

Similar Datasets

| S-EPMC6925655 | biostudies-literature
| S-EPMC7350275 | biostudies-literature
| S-EPMC5531036 | biostudies-other
| S-EPMC5823339 | biostudies-literature
| S-EPMC6830138 | biostudies-literature
| S-EPMC4833321 | biostudies-literature
| S-EPMC4012799 | biostudies-literature
| S-EPMC9203422 | biostudies-literature
| S-EPMC2851523 | biostudies-literature
| S-EPMC7853588 | biostudies-literature